ZA897517B - Method of inhibiting onset of or treating migraine headache using a thromboxane a2 receptor antagonist - Google Patents

Method of inhibiting onset of or treating migraine headache using a thromboxane a2 receptor antagonist

Info

Publication number
ZA897517B
ZA897517B ZA897517A ZA897517A ZA897517B ZA 897517 B ZA897517 B ZA 897517B ZA 897517 A ZA897517 A ZA 897517A ZA 897517 A ZA897517 A ZA 897517A ZA 897517 B ZA897517 B ZA 897517B
Authority
ZA
South Africa
Prior art keywords
thromboxane
receptor antagonist
migraine headache
treating migraine
inhibiting onset
Prior art date
Application number
ZA897517A
Other languages
English (en)
Inventor
Martin Lawrence Ogletree
Lawrence Ogletree Martin
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA897517B publication Critical patent/ZA897517B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA897517A 1988-10-07 1989-10-03 Method of inhibiting onset of or treating migraine headache using a thromboxane a2 receptor antagonist ZA897517B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/254,899 US4839384A (en) 1988-10-07 1988-10-07 Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist

Publications (1)

Publication Number Publication Date
ZA897517B true ZA897517B (en) 1990-06-27

Family

ID=22966012

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897517A ZA897517B (en) 1988-10-07 1989-10-03 Method of inhibiting onset of or treating migraine headache using a thromboxane a2 receptor antagonist

Country Status (10)

Country Link
US (1) US4839384A (da)
EP (1) EP0362587A3 (da)
JP (1) JPH02145518A (da)
AU (1) AU626917B2 (da)
CA (1) CA1336686C (da)
DK (1) DK495089A (da)
HU (1) HU206826B (da)
NZ (1) NZ230914A (da)
PT (1) PT91923A (da)
ZA (1) ZA897517B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975279A (en) * 1989-10-10 1990-12-04 E. R. Squibb & Sons, Inc. Method of improving post-ischemic myocardial function using a thromboxane A2 antagonist in combination with a thrombolytic agent and combination
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
GB9720270D0 (en) * 1997-09-25 1997-11-26 Pharmagene Lab Limited Medicaments for the treatment of migraine
US20030158240A1 (en) * 1998-09-25 2003-08-21 Pharmagene Laboratories Limited Methods for the treatment of primary headache disorders using prostanoid EP4 receptor antagonists, and assays for agents for such treatment
WO2001089519A1 (en) * 2000-05-22 2001-11-29 Nitromed, Inc. Thromboxane inhibitors, compositions and methods of use related applications
US6284790B1 (en) 2000-06-15 2001-09-04 Sachin Gupte Methods of potentiating organic nitrates having vasodilating activity and formulations for the same
ES2848348T3 (es) 2014-05-16 2021-08-06 Cumberland Pharmaceuticals Inc Composiciones y métodos de tratamiento con ifetroban de la fibrosis cardíaca
KR102448406B1 (ko) 2015-06-30 2022-09-27 큠버랜드 파마슈티컬즈 인코포레이티드 Ａｅｒｄ/천식에서 트롬복산 수용체 길항제
AU2017263462B2 (en) 2016-05-11 2021-05-13 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists
KR102687556B1 (ko) 2017-11-29 2024-07-22 반더빌트유니버시티 종양 전이를 억제하는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537981A (en) * 1981-11-09 1985-08-27 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene compounds
GB2146473B (en) * 1983-09-10 1987-03-11 Standard Telephones Cables Ltd Addressing liquid crystal displays
GB8511894D0 (en) * 1985-05-10 1985-06-19 Ici Plc Phenol derivatives
GB8511895D0 (en) * 1985-05-10 1985-06-19 Ici Plc Heterocyclic compounds
US4663336A (en) * 1985-07-01 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease
ATE56967T1 (de) * 1985-11-12 1990-10-15 Ici Plc Amidderivate.

Also Published As

Publication number Publication date
HUT58517A (en) 1992-03-30
DK495089A (da) 1990-04-08
EP0362587A3 (en) 1991-07-24
HU895248D0 (en) 1990-01-28
AU4254089A (en) 1990-04-12
EP0362587A2 (en) 1990-04-11
US4839384A (en) 1989-06-13
NZ230914A (en) 1997-06-24
AU626917B2 (en) 1992-08-13
DK495089D0 (da) 1989-10-06
PT91923A (pt) 1990-04-30
HU206826B (en) 1993-01-28
JPH02145518A (ja) 1990-06-05
CA1336686C (en) 1995-08-15

Similar Documents

Publication Publication Date Title
GB8809989D0 (en) Method of restraining vibration of structure & apparatus therefor
GB2215257B (en) Apparatus for reflex-percussive cutting of concrete etc.
ZA897517B (en) Method of inhibiting onset of or treating migraine headache using a thromboxane a2 receptor antagonist
IL99115A0 (en) Method of tool development
GB2224842B (en) Apparatus for generating downhole seismic energy
GB8816340D0 (en) Method of & means for building
GB9404032D0 (en) Process for inhibiting scale formations
GB2245607B (en) Method of surface-finishing for concrete member
EP0439305A3 (en) Methods of generating data for numerically controlled machine tools
EG18973A (en) Method for preventing scale formation
CS108389A2 (en) Method of new trisubstituted amines production
GB8808246D0 (en) Method for restraining vibration of building & structure therefor
GB8812809D0 (en) Method & device for ensuring minimum thickness render coat
ZA90337B (en) Method of preventing or treating atherosclerosis using a thromboxane a2 receptor antagonist
GB8811963D0 (en) Method of & apparatus for patterning solid workpieces
EG18366A (en) Method and device for inhibiting the end-faces of a block of propellant and propellant block obtained by this process
HUT60799A (en) Method for forming well of small depth
HUT70829A (en) Device of setting broken heel-bone usable for secret process
PL295073A1 (en) Method of obtaining novel (+)-cis-2-hydroxy-trans-2-]2-hydroxy-3-n, isopropylamino)-propylo¦-cis-dihydropinole hydrochloride
SG50695A1 (en) Method of surface-treating workpiece
PL294824A1 (en) Apparatus of protecting wells using the cavitation method
PL274419A1 (en) Method of producing of alpha-izopropilo-alpha-(n-methylo-n-homoveratrilo)-gamma-aminopropylo-3,4-dimethoxyphenyltacetonitrile hydrochloride
EG19640A (en) Process for preparing of triazole antifungal agents
PL273598A1 (en) Method for hydratation of lime
RU1806994C (en) Method of control of ammonia synthesis process